Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer

Five years of adjuvant tamoxifen therapy for estrogen receptor (ER) -positive breast cancer is more effective than 2 years of use. However, information on tamoxifen discontinuation is scanty. We sought to identify predictors of tamoxifen discontinuation among older women with breast cancer. Within s...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical oncology Jg. 26; H. 4; S. 549
Hauptverfasser:	Owusu, Cynthia, Buist, Diana S M, Field, Terry S, Lash, Timothy L, Thwin, Soe Soe, Geiger, Ann M, Quinn, Virginia P, Frost, Floyd, Prout, Marianne, Yood, Marianne Ulcickas, Wei, Feifei, Silliman, Rebecca A
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 01.02.2008
Schlagworte:	Aged Aged, 80 and over Breast Neoplasms - drug therapy Breast Neoplasms - metabolism Breast Neoplasms - pathology Female Humans Life Tables Lymphatic Metastasis Medical Records - standards Neoplasm Recurrence, Local - prevention & control Neoplasm Staging Patient Compliance - statistics & numerical data Receptors, Estrogen - metabolism Selective Estrogen Receptor Modulators - administration & dosage Tamoxifen - administration & dosage Treatment Outcome
ISSN:	1527-7755, 1527-7755
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!